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Abstract
Mutations in the gene encoding the immunoglobulin-superfamily member cell adhesion molecule contactin1 (CNTN1)
cause lethal congenital myopathy in human patients and neurodevelopmental phenotypes in knockout mice. Whether the
mutant mice provide an accurate model of the human disease is unclear; resolving this will require additional functional
tests of the neuromuscular system and examination of Cntn1 mutations on different genetic backgrounds that may
influence the phenotype. Toward these ends, we have analyzed a new, spontaneous mutation in the mouse Cntn1 gene
that arose in a BALB/c genetic background. The overt phenotype is very similar to the knockout of Cntn1, with affected
animals having reduced body weight, a failure to thrive, locomotor abnormalities, and a lifespan of 2–3 weeks. Mice
homozygous for the new allele have CNTN1 protein undetectable by western blotting, suggesting that it is a null or very
severe hypomorph. In an analysis of neuromuscular function, neuromuscular junctions had normal morphology, consistent
with previous studies in knockout mice, and the muscles were able to generate appropriate force when normalized for their
reduced size in late stage animals. Therefore, the Cntn1 mutant mice do not show evidence for a myopathy, but instead the
phenotype is likely to be caused by dysfunction in the nervous system. Given the similarity of CNTN1 to other Ig-superfamily
proteins such as DSCAMs, we also characterized the expression and localization of Cntn1 in the retinas of mutant mice for
developmental defects. Despite widespread expression, no anomalies in retinal anatomy were detected histologically or
using a battery of cell-type specific antibodies. We therefore conclude that the phenotype of the Cntn1 mice arises from
dysfunction in the brain, spinal cord or peripheral nervous system, and is similar in either a BALB/c or B6;129;Black Swiss
background, raising a possible discordance between the mouse and human phenotypes resulting from Cntn1 mutations.
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Introduction
This paper reports a spontaneous mutation in the mouse
contactin 1 (Cntn1) gene (MGI: 105980). CNTN1 is an
immunoglobulin (Ig) superfamily member cell adhesion molecule
of 1020 amino acids, consisting of six Ig domains, four fibronectin-
like repeats (FN), and a GPI-linkage at the carboxy-terminus
anchoring the protein to the extracellular plasma membrane [1].
The gene is expressed broadly and robustly in the central and
peripheral nervous system. Like many Ig-superfamily proteins,
CNTN1 is implicated in numerous neurodevelopmental functions
in vitro, including neurite extension, repulsion, and fasciculation
[2–7]. Furthermore, CNTN1 interacts with several extracellular
proteins, including other Ig-domain proteins, tenascins, phospha-
can, and contactin-associated proteins (Casprs) [4,8–14].
In humans, mutations in CNTN1 cause a familial form of lethal
congenital myopathy (Compton-North congenital myopathy,
OMIM ID# 612540), a disease characterized by congenital onset
muscle weakness and myopathic features in biopsy samples [15].
There is also a secondary loss of syntrophin and dystrobrevin
immunoreactivity from neuromuscular junctions (NMJs) of
affected individuals [16]. This condition was mapped to
Chromosome 12, and a frame shift mutation in CNTN1
introducing a premature stop codon (S291fsX296) was identified
by sequencing candidate genes within the genetic interval.
Consistent with the disease presentation, CNTN1 is found at
NMJs in both humans and mice [15].
In mice, the Cntn1 gene has been deleted by targeting exon 3
using homologous recombination, and the mutation was main-
tained in a mixed 129/SvJ6C57BL/66Black Swiss genetic
background [17]. Mice lacking Cntn1 do not have obvious
myopathy or defects in syntrophin and dystrobrevin localization
at NMJs, and NMJ morphology is normal in the mutant animals
[15]. However, Cntn1 clearly does serve an important neurode-
velopmental function in mice. Mice lacking Cntn1 have ataxia, fail
to thrive, and die within 2–3 weeks of birth. Defects in both axon
and dendrite development in the cerebellum were observed [17].
In addition, in the peripheral nervous system, CNTN1 is found at
the paranodal axolemma, and mice lacking Cntn1 have reduced
nerve conduction velocities and mislocalization of Kv1.1 and
Kv1.2 potassium channels [18]. Given the gene’s widespread
neuronal expression and severity of the Cntn1 knockout phenotype,
it seems likely that there are additional neurological phenotypes in
the Cntn1 mice.
The studies in mice have confirmed that mutations in Cntn1
cause a severe, early onset phenotype. However, it is unclear
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possible that there are functional deficits in muscle or neuromus-
cular junctions that are not evident by histology and immunocy-
tochemistry. It is also possible that different Cntn1 alleles or
different genetic backgrounds could change the phenotype so that
it more closely resembles the human disease.
We have begun to address these issues by studying a new,
spontaneous mutation in Cntn1 that arose on an inbred BALB/c
genetic background. In these mice we examined NMJs and muscle
function to assess this new mutation as a model for congenital
myopathy. Furthermore, based on the similarity of CNTN1 to
other Ig-superfamily members such as the DSCAMs, we have
examined the retina for developmental phenotypes.
Materials and Methods
Mice
The Cntn1 mutant was discovered in The Jackson Laboratory
Production colony of BALB/cJ in 1979 by animal care technician
Lynn O’Neal. To improve reproduction the mutation was
outcrossed once to mice of the BALB/cByJ genetic background.
All mice were maintained and crosses carried out in the Mouse
Mutant Resource (MMR) at The Jackson Laboratory [19]. Mice
are maintained in a room with HEPA-filtered air and a 14:10
light:dark cycle. They currently are fed 5K52 6% fat diet
(LabDiet.com) and acidified (pH 2.5–3.0) water ad libitum. All
studies were performed in accordance with the National Institutes
of Health Guide for the Care and Use of Laboratory Animals
(National Resource Council), and all procedures were approved by
The Jackson Laboratory Institutional Animal Care and Use
Committee. Comprehensive protocol #01026 (approval dates
Nov. 29, 2007 and Oct. 28, 2010) covered the portion of the study
done in Dr. Burgess’ laboratory and comprehensive protocol
#99066 (approval dates July 8, 2010 and June 21, 2011) covered
the portion of the study done in Dr. Davisson’s laboratory.
Genetic analysis
Genetic mapping of this new mutation spans the history of
mutant gene mapping in the mouse. In the early 1980s, the
mutation was tested for chromosomal linkage with visible and
polymorphic isoenzyme markers on 15 different chromosomes
using intercrosses with linkage testing stocks (stocks carrying
multiple mutations that cause visible phenotypes). In linkage
crosses and tests for allelism, all mice were classified visually
between 10 and 20 days of age. Intercross linkage estimations were
calculated using a computer program based on Fisher’s Tables
[20]. In 1999 the mutant was recovered from the cryopreserved
state for more studies and in 2009–2010 mapped more precisely
using an intercross with DBA/2J and DNA markers – simple
sequence and single nucleotide polymorphisms (SSLPs, SNPs). A
female transplanted with homozygous ovaries was mated to a
DBA/2J male and obligate heterozygous F1s intercrossed. In this
intercross, homozygous mutants were genotyped and the data
analyzed as backcross data, giving two chromosomes per mutant
mouse.
Histological analysis
Mice were euthanized with CO2 asphyxiation. Tissues from
mutant and control littermate mice were fixed in Bouin’s fixative,
paraffin embedded, sectioned at 4 mm, and stained with
hematoxylin and eosin (H&E) in an automated slide processor
(Leica). Frozen sections of livers were stained with oil red O to
determine if the pale appearance resulted from fat deposition.
Immunostaining
Cerebellar Purkinje cells were stained with an antibody against
calbindin (rabbit anti-calbindin, Chemicon, D-28K at 1:400) using
tissue prepared as above for histology. Signal detection used an
avidin-biotin-amplified peroxidase-coupled secondary antibody
and Diaminobenzidine chromogenic substrate (Vector Labs) with
hematoxylin counterstaining of nuclei.
Retinas were stained using indirect immunofluorescence. Tissue
was fixed in 4% buffered paraformaldehyde, cryoprotected in 30%
sucrose, and embedded in OCT medium. Samples were then
sectioned on a cryostat and mounted onto glass slides for staining.
The following primary antibodies were used: Smi-32 mouse anti-
non-phosphorylated neurofilament (Covance, SMI-32R at 1:500),
Rabbit anti-melanopsin (generously provided by Ignacio Proven-
cio, Uniformed Services University of the Health Sciences, at
1:10,000), sheep anti-Tyrosine hydroxylase at 1:1000 (Millipore
AB1542), goat anti-ChAT (Millipore, AB144P at 1:500), rabbit
anti-PKCa (Sigma-Aldrich, P4334 at 1:1000), rabbit anti-bNOS
(Sigma-Aldrich, 1:1000), rabbit anti-disabled (generously provided
by Dr. Brian Howell, at 1:500), and goat anti-CNTN1 (R&D
Systems, AF904). Appropriate secondary antibodies conjugated to
AlexaFluor dyes for visualization were used (Invitrogen) with the
exception of anti-sheep secondaries, which were Cy3 conjugated
(Jackson Immunoresearch). Images were collected on a Zeiss Axio
Observer Z1 inverted microscope with a Zeiss Axio Cam digital
camera using the software’s extended focus function.
Muscle cross sections were prepared and stained as above using
rabbit polyclonal antibodies against dystrobrevin and syntrophin
(generously provided by Dr. Marvin Adams, University of
Washington). The following antibodies were used, anti-a1-
syntrophin (258 at 1:200), anti-b1-syntrophin (248 at 1:100),
anti-b2-syntrophin (149 at 1:50), anti-a-dystrobrevin (pan alpha,
recognizing a-dystrobrevin 1 and 2, 141 at 1:1000), and anti-b-
dystrobrevin (143 at 1:1000). AlexaFluor 488 conjugated anti-
rabbit secondary antibodies were used for visualization. Neuro-
muscular junctions were counterstained with AlexaFluor 594
conjugated a-bungarotoxin to label nicotinic acetyl choline
receptors at the synapse (Invitrogen).
Neuromuscular junctions were visualized as described [21]. In
brief, muscles were dissected and fixed in freshly made 4%
buffered paraformaldehyde at 4uC for 4 hours. After rinsing in
PBS, tissue was partially teased to loosen the muscle fibers,
blocked, and permeabilized in PBS with 1% triton 6100 and 2%
Bovine Serum Albumin for 30 minutes. During this step, muscles
were compressed between two microscope slides with pressure
from a binder clip to flatten the muscle to improve imaging. A
cocktail of anti-neurofilament (2H3) and anti-SV2 (both from
Developmental Studies Hybridoma Bank) were applied in PBS/
triton/BSA overnight. Samples were washed extensively the next
day and an anti-mouse IgG1 specific secondary antibody
conjugated to AlexaFluor 488 was used to visualize nerves.
Acetylcholine receptors on the muscle were visualized with a-
bungarotoxin conjugated to AlexaFluor 594 (Invitrogen), which
was included with the secondary antibody. After twelve hours,
samples were washed and mounted in 80% glycerol and imaged
on a Leica SP5 confocal microscope.
Cntn1 expression in the retina
The expression of Cntn1 in the mouse retina was examined by in
situ hybridization. Digoxygenin-labeled (DIG) antisense riboprobes
recognizing Cntn1 were transcribed using T7 polymerase from full
length Cntn1 cDNA. Probes were then subjected to alkaline
hydrolysis at pH8.4 at 60uC for 10 minutes to produce probe
fragments (,200 bp), precipitated, resuspended in hybridization
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20 mm were postfixed in methanol (20 minutes, 220uC), treated
with proteinase K (10 minutes, RT), permeabilized with 1%
triton-X (30 minutes, RT), and then treated with 0.3% H2O2 to
block endogenous peroxidases. Next, tissue sections were im-
mersed in hybridization buffer without probe for 1 hr at RT and
then immersed in hybridization buffer with probe overnight at
65uC. The following day, sections were washed in sodium citrate
buffer for 3–4 hrs at 65uC, rinsed in 0.3%TX in PBS and
processed for visualization. Signals were detected using an alkaline
phosphate-conjugated anti-DIG antibody and NBT colormetric
detection, or horseradish peroxidase-conjugated anti-DIG and
tyramide signal amplification for fluorescent double label in situs,
both according to the manufacturers protocols (Roche).
Immunofluorescence of anti-CNTN1 was performed using a
goat-anti-CNTN1 antibody (R&D Systems, AF904, 1:100). To
optimize antigenicity and reduce non-specific labeling, several
fixatives were tried, including paraformaldehyde prior to cryo-
embedding and sectioning, and methanol, ethanol/acetic acid, or
methanol/acetone fixation on cryostat-cut sections of fresh-frozen
tissue. Results varied with the fixative, but were generally
comparable. Acetic acid/ethanol fixation is shown based on the
strong signals in control tissue and the complete absence of signals
with the omission of the primary antibody (not shown). All mutant
and control samples were processed in parallel and all images were
collected under equivalent confocal parameters or camera
exposure times.
Candidate gene analysis
Based on the chromosomal location on Chromosome (Chr) 15
and the similarity of the phenotype to the published Cntn1
knockout phenotype, we analyzed Cntn1 function in affected
(presumed homozygous) mice. We assayed for CNTN1 protein by
western blotting of brain and spinal cord tissue homogenates using
standard techniques. Tissues were frozen in liquid nitrogen and
stored at 280uC. The tissues were then homogenized in 1% NP-
40 in phosphate buffered saline (PBS) supplemented with Protease
Inhibitor Cocktail Tablets (Roche, Basal, Switzerland) using a
PowerGen Model 125 Homogenizer (Fisher Scientific, Pittsburgh,
PA) then centrifuged at 14,000 g for 10 minutes at 4uC. Cleared
homogenates were then sonicated at 4uC and centrifuged again at
14,000 g for 10 minutes. Protein concentrations were assessed
using a Bradford assay (BioRad, Hurcules, CA). 20 mg of protein
was then analyzed by immunoblot. Protein lysates were resolved
on Novex 10% Tris-Glycine Gels (Invitrogen, Carlsbad, CA) and
transferred to an Invitrolon PVDF membrane for western blot
analysis. Membranes were blocked with 5% skim milk in TBST
(16 Tris-buffered saline, 0.1% Tween-20), and incubated
overnight with CNTN1 goat polyclonal antibody (1:200, R&D
Systems, AF904) and b actin mouse monoclonal antibody clone
AC-74 (1:10,000, Sigma Aldrich, St. Louis, MO) diluted in
blocking solution at 4uC. Following three 10 minute washes in
TBST, the blots were incubated with the appropriate horseradish
peroxidase-conjugated secondary antibodies (Jackson ImmunoR-
esearch, West Grove, PA) diluted in blocking solution. After three
10-minute washes in TBST, the blots were developed using
Western Lightning Plus-ECL, Enhanced Chemiluminescence
Substrate (Perkin Elmer, Waltham, MA). We assayed for Cntn1
transcription by amplifying the Cntn1 gene from reverse tran-
scribed brain cDNA using overlapping primer combinations that
spanned the open reading frame. We also sequenced 11 of the 24
Cntn1 exons in genomic DNA isolated from affected mice using
standard Sanger sequencing methods. Because we were sequenc-
ing an already known and sequenced gene to look for causative
mutations, no new sequence was generated. Therefore, we did not
submit the sequence generated to GenBank.
In-vitro contractile properties
Mice were anesthetized with isoflurane and the extensor
digitorum longus (EDL) muscle was surgically exposed completely
from distal to proximal tendon. Silk suture thread (5.0, Sofsilk,
USA) was tied and secured with glue to form a small loop on each
tendon. Once suture loops were in place, the muscle was
completely freed and carefully removed and the anesthetized
mouse was killed by cervical dislocation. Excised muscles were
placed immediately in a custom organ bath filled with Krebs
Ringer solution (NaCl 137 mM; NaHCO3 24 mM; D-glucose
11 mM; KCl 5 mM; CaCl2 2 mM; NaH2PO4H2O 1 mM;
MgSO4 1 mM). The solution was bubbled with 5% CO2 in
95% oxygen, maintained at 25uC (Warner Instruments Model TC
324B, USA), and circulated continuously through the bath.
The sutures on proximal and distal tendons were attached,
respectively, to a hook connected to a force transducer (Aurora
Instruments, Dual Mode Lever System, Toronto, CA) and a post
fixed permanently in the bath. Two platinum plate electrodes that
flanked the muscle longitudinally were connected to a stimulator
for delivery of supramaximal square-wave pulses (0.2 ms duration,
Aurora Instruments, Biphase Current Stimulator, Toronto, CA) to
produce isometric contractions. The force transducer is mounted
on a micromanipulator that allows optimum muscle length (Lo) to
be established by maximizing twitch force amplitude.
Once Lo was established, experiments consisted of eliciting and
recording maximum isometric twitch force (Pt) from which
measures of time to peak twitch (TPT) and half relaxation time
(1/2 RT) were also derived. Twitches were elicited with single
stimuli (0.2 ms duration, 0.5 pps). Isometric tetanic force (Po) was
also recorded in response to a 4 pulse stimulus train at 80 pulses
per second (PPS). Force data were digitized (Aurora Instruments,
Toronto, CA) and recorded on a PC-based computer. Calipers
were used to measure muscle length at Lo through a dissecting
scope (Leica MZ6) mounted over the preparation. At the end of
the experiment the muscle was removed from the bath and
weighed.
Results
Phenotype
By 4–7 days after birth mutant mice are smaller than their
littermates; by two weeks they appear emaciated and ataxic. About
80% of homozygous pups die by 18–20 days of age; the remaining
20% die by 30 days of age. Gross autopsies of two- and three-
week-old pups revealed hardly any food in the stomach, intestines
full of gas bubbles and pale livers. Frozen liver sections stained
with oil red O showed fat deposits characteristic of fat mobilization
in starving mice. Histopathologic screening of all tissues, as is
routine in the MMR, failed to reveal obvious abnormalities.
Likewise, no morphological anomalies were observed in brains
stained with LFB and PAS. Calbindin immunostaining of
cerebellar Purkinje cells showed normal dendritic arborization
(data not shown) similar to knockout mice.
Genetic Analysis
Mode of Inheritance. This mutation is inherited as an
autosomal recessive. Heterozygotes are not visibly affected. The
male from the original trio carrying the mutation was outcrossed
to a B6C3H F1 (C57BL/6J6C3H/HeSnJ) female and produced
one pair of normal appearing (+/?) F1 mice that subsequently
produced 5 mutant mice and 30 normal mice. F1 mice from an
A Spontaneous Mutation in Contactin 1 in the Mouse
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initial matings between heterozygotes in the colony (confirmed by
the production of at least one affected mutant) produced 31
mutant and 90 +/? mice for a frequency of 27.7% (96 mutants/
346 total mice), which is not statistically different from the
expected 25%.
Chromosomal assignment. Initial linkage crosses in 1989
with visible markers revealed linkage with caracul (Krt71
Ca) on Chr
15 (10.863.4; n=303) in a backcross-intercross. A subsequent
repulsion intercross with two other Chr 15 markers, underwhite
(Slc45a2
uw) and belted (Adamts20
bt), confirmed the distal location on
Chr 15 (Slc45a2
uw–38.2063.49 – new mutation, Adamts20
bt;
n=584). In 2009, in an effort by MMR scientists to identify the
mutated genes in old spontaneous mutations, this mutation was
more precisely mapped using an intercross with DBA/2J. In this
intercross the mutation was localized between D15Mit242 at
90.2 Mb and D15Mit192 at 92.7 Mb [D15Mit242 – 1/104
chromosomes=.9% - new mutation – 3/104=2.9% -
D15Mit192]. One of the eleven protein coding genes in this
interval was the contactin 1 (Cntn1) gene spanning 91.8–92.1 Mb
(Figure 1A). This region is conserved in human Chr 12 and human
CNTN1 maps at 12q11–q12 [22]. Two polymorphic SNPs
flanking Cntn1 (rs32088727 448 bp upstream and rs31768105
1889 bp downstream) were genotyped in the DNAs of the 4
mutant mice with recombinations between the MIT markers
flanking the mutation. All 4 homozygous mutants were
homozygous for the BALB parental Cntn1 alleles.
Candidate gene analysis
Given the similarity of the mutant phenotype to that of Cntn1
knockout mice, and the lack of compelling evidence suggesting a
mutation in one of the other genes in the interval might be causing
the phenotype, we analyzed Cntn1 in affected animals. CNTN1 is
an Ig-superfamily cell adhesion molecule of 1020 amino acids that
is known to cause neurodevelopmental phenotypes when mutated
in mice [17] (Figure 1B). In cDNA prepared from mutant brain
mRNA, it was very difficult to reliably amplify regions of the Cntn1
open reading frame for sequencing, although other genes could be
amplified from the same samples, suggesting a severe, specific
decrease in Cntn1 mRNA levels. Consistent with this, immuno-
blotting with an anti-CNTN1 antibody revealed a complete failure
to detect CNTN1 protein in homogenates from affected mice,
whereas a band of the appropriate size was readily detectable in
samples from unaffected littermates (Figure 1C). The reduction of
protein to levels below detection by western blotting indicates that
the mutation in the Cntn1 gene, which we have designated Cntn1
J,
is a null or very severe hypomorph. Although we have not
identified the precise molecular lesion in the genomic DNA yet,
with 11 exons from the 24 exon transcription unit sequenced with
good coverage, we have strong evidence that the mutation is in
Figure 1. Contactin1 as a candidate gene for this mutation. A) The genetic interval of Chromosome 15 between D15Mit242 and D15Mit192
(2.5 Mb) is shown. Genomic features including protein-coding genes are indicated. The image is from the Ensembl genome browser (http://ensembl.
org/index.html). B) The structure of CNTN1 is schematized; the protein has an N-terminal signal peptide for secretion, 6 immunoglobulin domains (Ig),
4 fibronectin repeats (FN), and a GPI-linked carboxy-terminal modification for attachment to membranes. C) Immunoblot of CNTN1 in spinal cord and
brain from two unaffected littermate control mice and two affected mice reveals an absence of CNTN1 protein in the affected mice. b-actin was used
as a loading control.
doi:10.1371/journal.pone.0029538.g001
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interval containing Cntn1 on Chr. 15, 2) Cntn1 and the mutant
phenotype co-segregated in four animals with recombinations
within the interval, 3) the phenotype closely resembles the reported
Cntn1 phenotype, and 4) Cntn1 mRNA and protein are drastically
reduced or absent. Thus, we feel it is very unlikely that the
mutation could be in another gene in the interval with the
secondary effect of eliminating Cntn1 expression.
Neuromuscular function assessment
Consistent with previous studies, neuromuscular junctions in
Cntn1 mutant animals had normal morphology [15] (Figure 2A, B).
In control mice at postnatal day 11 (P11), the postsynaptic
acetylcholine receptor field on the muscle membrane (labeled in
red with a-bungartoxin) is becoming convoluted but has not yet
assumed its mature pretzel-like shape. The motor nerve terminal
(labeled in green with antibodies against neurofilament and SV2)
fully overlaps the receptor field and fills the developing troughs in
the muscle. A very similar morphology was observed in the mutant
muscle, and there was no evidence of delayed maturation, partial
or complete denervation, or dystrophic axons or nerve terminals.
Similarly, histopathological examination of muscle did not reveal
myopathy, fibrosis, neurogenic atrophy, or central myonuclei
indicative of regenerating muscle fibers, although muscle fibers
were smaller consistent with the smaller size of the mice (Figure 2
C–F). Similar results were obtained upon closer examination of
muscle anatomy using transmission electron microscopy (Figure 2
G, H). Sarcomere structure and organization appeared normal in
two mutant tibialis anterior muscles examined at P13. For
example, sarcomeres were of uniform size and Z-lines were in
register.
Such a lack of clear histopathological findings in mice with such
a striking and severe phenotype typically indicates a functional
deficit that does not impact anatomy. Since the human disease
associated with CNTN1 mutations is categorized as a congenital
myopathy, we examined this functionally in muscle. Using isolated
extensor digitorum longus (EDL) muscles from P13 mutant and
control mice (N=4 each), we tested muscle contractile properties
by direct stimulation of the muscle. The mutant mice are
dramatically smaller than littermates, and muscle weights were
similarly smaller (,60%) (Table 1). However, there was no
reduction in the muscle weight:body weight ratio, indicating that
muscle is not disproportionately affected. Consistent with the
reduced muscle weight, both the absolute twitch and tetanic force
generated by the mutant muscles were significantly reduced
compared to control (,70%), but when normalized for muscle
weight the force values were not different than control (Figure 2I, J
and Table 1). The time to peak tension of the mutant muscles was
also significantly slower (Table 1) and the half-relaxation time
showed a slowing trend that was not significant. These changes
may reflect secondary developmental differences in muscle
proteins (e.g. myosin ATPase). Taken together, the histopathology,
anatomy, and functional analysis of muscles in Cntn1 mutant mice
are inconsistent with a congenital myopathy, and suggest that the
severe locomotor phenotype is the result of dysfunction in the
nervous system, as previously suggested [17,18], and not in the
muscle itself.
Another feature of the myopathic patients is an alteration in
dystrobrevins and syntrophins, intracellular proteins associated
with the dystroglycan-glycoprotein complex in muscle [15,16].
Specifically, a1- and b1-syntrophin show their normal localization
to the muscle membrane; however, b2-syntrophin and a-
dystrobrevin are absent from the muscle membrane of patients,
although a-dystrobrevin is retained at the NMJ. Such changes
were not observed in the previously reported mice lacking Cntn1
[15]. To determine if the spontaneous allele of Cntn1 in a BALB/c
genetic background had altered dystrobrevin and syntrophin
localization in muscle, we stained muscle cross sections with
antibodies to a- and b-dystrobrevin and a1-, b1-, and b2-
syntrophin (Figure 3). Alpha-dystrobrevin was still clearly localized
at the muscle membrane and enriched at NMJs (labeled with a-
bungarotoxin) in both control and mutant samples (Figure 3 A, B).
Figure 2. Neuromuscular analysis of Cntn1 mutant mice. A) Neuromuscular junctions in wild type P11 mice have a plaque-like field of
postsynaptic acetylcholine receptors (red) that is beginning to become convoluted. This is completely overlapped by the presynaptic motor nerve
terminal (green). B) A similar NMJ morphology is seen in Cntn1 mutant mice. Histological examination of longitudinal and cross sections of control
(C,D), and mutant (E,F) hind limb muscles at P13 did not reveal hallmarks of myopathy. G,H) Transmission electron microscopy was used to evaluate
sarcomere anatomy in the tibialis anterior muscle. The structure was not adversely affected by the mutation. I) The absolute maximal contractile force
of the extensor digitorum longus muscle was reduced in mutant mice. J) When normalized for muscle weight, contractile force of mutant muscle was
not significantly different than control. The scale bar in H represents 14 mmi nA ,B ,7 2mm in C–F, and 3 mmi nG ,H .
doi:10.1371/journal.pone.0029538.g002
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similar distribution and NMJ enrichment that did not differ
markedly between control and mutant samples (Figure 3 C–H).
Staining for b2-syntrophin was weak even in control samples, but
staining at the NMJ was detectable in mutant muscles, although
extrasynaptic labeling was below detection (Figure 3 I, J).
Cntn1 expression in the retina
The retina provides an excellent system for examining
neurodevelopmental phenotypes because of its highly reproducible
anatomy and the availability of markers for numerous specific
neuronal cell types. Furthermore, a possible function for Cntn1 in
the retina has not been previously reported. We therefore
examined the retinas of the Cntn1 mutant mice; however, we first
determined the expression pattern of Cntn1 in wild type retinas to
better inform the choice of markers to be used to look for
phenotypes in the Cntn1 mutant retinas. By in situ hybridization,
Cntn1 is expressed by many but not all cells in the retinal ganglion
cell (RGC) layer (ganglion cells and amacrine cells) and in the
inner nuclear layer (amacrine, bipolar, horizontal cells, and Muller
glial cells). No expression above background was seen in the outer
nuclear layer (photoreceptors). This pattern was observed in the
developing retina (P5), and persisted through eye opening and in
the mature retina (P21, figure 4 A–C). Double in situ hybridization
with Cntn1 and syntaxin 1A (Syx1a), a marker of amacrine cells,
demonstrated that some amacrine cells do express Cntn1, but
additional cells in the inner nuclear layer (probably bipolar cells
based on their position) also express Cntn1 (Figure 4D). In the
retinal ganglion cell layer, double in situ hybridization with probes
against Thy1, a marker of RGCs, showed that most Cntn1-positive
cells in the ganglion cell layer are indeed ganglion cells (as opposed
to misplaced amacrine cells, Figure 4E).
Table 1. Additional in vitro contractile properties of directly
stimulated EDL muscles.
+/+ 2/2
Body weight (g) [BW] 8.16.0.2 3.360.4**
Muscle weight (mg) [MW] 2.760.2 1.160.2**
MW:BW ratio % 0.03460.0023 0.03360.0029
Pt (g) 1.260.4 0.3260.06*
Pt (N/g) 4.361.5 2.960.9
TPT (ms) 21.161.1 25.162.6*
1/2RT (ms) 32.263.7 36.967.5
*,0.03.
**,0.0001.
Muscle twitches recorded in mutant mice are smaller and have a longer time-
to-peak tension. Reduced absolute values are due to smaller muscles in
mutants because normalized twitch forces are not different from wild-type.
Similar outcome is shown for tetanic force in Figure 3. MW:BW ratio%, percent
muscle to body-weight; Pt(g), absolute twitch force; Pt (N/g), twitch force
normalized to muscle weight; TPT, time-to-peak twitch tension; 1/2RT-twitch
half-relaxation time; N, Newtons (force); ms, milliseconds.
doi:10.1371/journal.pone.0029538.t001
Figure 3. Dystrobrevin and Syntrophin localization in Cntn1 mutant muscle. Cross sections of triceps surae from three mutant and three
littermate control mice (ages P14, P15, and P16) were labeled with antibodies recognizing dystrobrevins and syntrophins (green). NMJs were
counterstained with a-bungarotoxin (red). Merged images as well as the green channel with NMJs denoted by arrowheads are shown. Immunolabels
are noted at left, genotypes are noted at top (control left, mutant right). The scale bar in the lower right is 25 mm.
doi:10.1371/journal.pone.0029538.g003
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retinas revealed strong staining in the inner and outer plexiform
layers of the retina, as well as in the inner nuclear layer, consistent
with CNTN1 localization on the processes of ganglion, amacrine,
and bipolar neurons (Figure 4F). The anti-CNTN1 labeling was
somewhat dependent on fixation and staining conditions (see
methods), although the conclusion that CNTN1 is abundantly
expressed in the retina and largely localized to the plexiform layers
was consistent. The specificity of the immunolabeling was tested
by staining sections from mutant retinas prepared, labeled, and
imaged in parallel with littermate control samples. The signal was
markedly reduced in the retinas of mutant mice, but not
eliminated (Figure 4G). Given the absence of signal in western
blots from the mutant animals, this residual staining may reflect
nonspecific antibody background, or a low level of CNTN1
protein still being produced by this allele. Considering the
sensitivity and excellent signal to noise ratio of the western blot,
we prefer the former explanation, but we cannot rule out the
latter. Regardless, these results indicate that numerous cell types in
the mouse retina express Cntn1, raising the possibility of a
developmental phenotype in the retina in the Cntn1 mutant
animals.
Normal retinal development in Cntn1 mutant mice
The broad expression of Cntn1 in the retina suggests a functional
role in retinal development. In addition, other Ig-superfamily
members with very similar extracellular domain structures, such as
the DSCAMs or Sidekicks, cause developmental defects in the
mouse and chick retina when mutated [23–26]. Since it is unknown
if the full scope of Cntn1 neurodevelopmental phenotypes has been
described, we examined retinas in Cntn1 mutant mice to determine
if similar defects would be evident. Upon histological examination,
the normal layering of the retina was present and was well
organized. Defects were not seen in the peripheral retina or at the
optic nerve head, the point at which retinal ganglion cell axons exit
the eye to form the optic nerve (Figure 5 A–D). Antibodies
recognizing specific cell types in the retina were also used to label
sections. This is a more sensitive examination of retinal anatomy
that can detectmisplaced cell bodies that may have failed to migrate
properly, supernumerary or under-represented cells of a given type,
and defects in dendrite arborization, which normally is restricted to
specific strata in the synaptic plexiform layers for a given cell type.
No defects in retinal anatomy were detected. The following cell
types were examined: AII amacrine cells (Disabled1-positive),
intrinsically photoresponsive retinal ganglion cells (melanopsin-
positive), horizontal cells (calbindin positive), starburst amacrine
cells (choline acetyltransferase-positive), bNOS-positive amacrine
cells,rodbipolarcells(proteinkinaseC-alpha-positive),alpharetinal
ganglion cells (SMI-32/neurofilament-positive), and dopaminergic
amacrine cells (tyrosine hydroxylase-positive). Similar results were
obtained in an independent examination of Cntn1 mutant retinas,
which additionally determined that glycinergic amacrine cells
(VGLUT3-positive) and a mixed population of monostratified
retinal ganglion cells (KV4.2-positive) were also normal in the
absence of Cntn1. Representative images of intrinsically photo-
responsive retinal ganglion cells, starburst amacrine cells, and
dopaminergic amacrine cells are shown (Figure 5 E–H). Thus, the
loss of Cntn1 does not impact the retina as prominently as other
related proteins such as DSCAMs, but subtle defects in other cell
types may have escaped detection.
Discussion
We have identified a new, spontaneous mutation in BALB/c
mice that maps to Chromosome 15 and results in a null allele of
Cntn1. The phenotype of these mice closely resembles the reported
phenotype of Cntn1 targeted knockout mice [17]. The homozygous
animals are smaller than littermates by a week of age, have
abnormal locomotor function, and die by a few weeks of age.
Neuromuscular junctions and muscle in the homozygous animals
are anatomically normal, and an examination of the retina for other
neurodevelopmental phenotypes did not reveal any defects. These
results indicate that the loss of Cntn1 causes a severe and early onset
phenotype that is consistent across multiple genetic backgrounds,
but that the phenotype in mice differs from human Compton-North
congenital myopathy in the backgrounds studied to date.
The difference in phenotype in mice and humans presents
several interesting questions. Although we do not favor this
hypothesis, it is a possibility that the CNTN1 mutation identified in
patients is not the cause of the lethal congenital myopathy. The
mutation was found in three affected individuals in a single
consanguineous family [15]. Mapping localized the mutation to an
interval on Chromosome 12 containing CNTN1 and 75 other
protein-coding genes. Expression analysis from muscle indicated
Figure 4. Expression and localization of Cntn1 in the retina. A–C
In situ hybridization for Cntn1 expression in the wild type mouse retina
at P5 (A), P10 (B), and P21 (C). A subset of cells in the retinal ganglion
cell layer (bottom) and inner nuclear layer are positive for Cntn1
expression. Photoreceptors in the outer nuclear layer (top) do not have
signals above background. D) Double label in situ hybridization with
Cntn1 and syntaxin1a at P21 demonstrates that some amacrine cells in
the inner nuclear layer are positive for Cntn1 expression (arrowheads).
Other Cntn1-positive cells are likely to be bipolar cells based on their
position (arrows). E) In the retinal ganglion cell layer, a majority of cells
expressing Cntn1 at P21 also express Thy1, a marker of ganglion cells. F)
Immunolabeling of retinas with anti-CNTN1 antibodies at P14 revealed
strong labeling of the synaptic plexiform layers, as well as immunore-
activity in the cellular layers, particularly the inner nuclear layer. G)
Immunolabeling retinas from Cntn1 mutant mice revealed a marked
reduction, but not an elimination of signal intensity in images collected
with equivalent parameters.
doi:10.1371/journal.pone.0029538.g004
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individuals, but CNTN1 showed the greatest change, with
undetectable expression in the affected patients. Of the fourteen
genes, seven were sequenced (as well as 18 other candidates) and
no changes were found except in CNTN1. In addition to the
undetectable level of expression, CNTN1 contained an early frame
shift mutation, making it the strongest candidate gene. For the
CNTN1 mutation to not be the causative factor, one would have to
invoke a second closely linked mutation that results in congenital
lethal myopathy before a later CNTN1 phenotype could arise. This
seems very unlikely. Another interesting possibility is that a
truncated amino-terminal fragment of CNTN1 may be produced
in these patients, and may cause a pathological effect on muscle.
As more alleles of CNTN1 are identified in humans, it will be
interesting to see if the severe myopathy is a reproducible feature
of the phenotype, or if it is selectively found in truncating
mutations like S291fsX296. The mouse muscle does show a trend
toward reduced force, even when normalized for its smaller size.
Our stimulation protocol was chosen because it approximates
physiological conditions, other more demanding protocols may
have revealed decreased contractile function in the mutant muscle
that may be indicative of a myopathy. Finally, it may be
misleading to think of the mouse myopathy phenotype as less
severe or absent, when the situation may be that the mouse
neurological phenotype is more severe and proves lethal before the
myopathy phenotype is evident.
Perhaps the most likely explanation for the discrepancy between
the mouse and human phenotypes is simply species differences.
This may reflect a difference in expression pattern. The mouse
gene is not abundantly expressed in muscle, whereas CNTN1 was
detectable on microarrays from control patient muscle biopsies.
Similarly, mice may be better able to compensate for the loss of
Cntn1 by upregulating related genes, such as Cntn2-4. Finally, the
resistance of mouse muscles to degeneration is seen in other
mutations, such as dystrophin, mutations, which cause severe
Duchenne muscular dystrophy in people, but a comparatively
mild phenotype in the mdx/mdx mouse. These differences in
severity may be a function of the smaller size or decreased physical
loads in mouse muscles, or may represent a more fundamental
difference in muscle biology between mice and humans.
While it remains to be determined if mouse Cntn1 mutations are a
good model of human CNTN1-associated disease, the striking
phenotype of the Cntn1 mutant mice indicates that they are still an
excellent system for understanding the biology of CNTN1 function at
t h ec e l l u l a ra n dm o l e c u l a rl e v e l s .F o re x a m p l e ,m o u s eC N T N 1i s
critically involved in the formation of septate-like junctions and the
localization of ion channels to the node and paranodal regions of
peripheral Schwann cells [18,27]. The molecular interactions
underlying these functions will undoubtedly shed light on the function
of CNTN1 in general in other regions of the central nervous system
or in other tissues. Consistent with this, Cntn1 mutant mice have
defects in the hypothalamus that may impact feeding behavior, but
hand feeding did little to prolong lifespan indicating that this is only
part of the neurological impairment affecting these mice [28].
The new mutation in Cntn1 identified in this study further
confirms the important role for this gene in mouse development
and indicates that the phenotype resulting from the loss of Cntn1 is
not highly sensitive to genetic background effects. Furthermore,
these studies indicate that other neurodevelopmental processes,
such as stratification of the retina, are not affected by the loss of
Cntn1. Discrepancies between the mouse and human phenotype
merit further investigation. If the primary phenotype of CNTN1
mutations in people is a myopathy, then understanding why this is
not a prominent aspect of the mouse phenotype may lead to
possible therapeutic strategies for CNTN1-related diseases.
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Figure 5. Normal retina development in Cntn1 mutant mice. A,B)
The retina and optic nerve head of wild type and Cntn1 mutant mice
stained with H&E did not reveal any defects. C,D) More peripheral areas
of the retina were also normal in the mutant. E,F) Staining for
dopaminergic amacrine cells (red, anti-tyrosine hydroxylase) and
horizontal cells and calbindin-positive amacrine cells (anti-calbindin,
green), showed that cell bodies and dendritic arbors of these cells were
in the appropriate anatomical location. G,H) Staining for intrinsically
photoresponsive ganglion cells (anti-melanopsin, green) and starburst
amacrine cells (anti-choline acetyltransferase, red) showed that these
cells were also unaffected by the loss of Cntn1. The scale bar in H
represents 145 mm in A–D and 72 mm in E–H.
doi:10.1371/journal.pone.0029538.g005
A Spontaneous Mutation in Contactin 1 in the Mouse
PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e29538References
1. Gennarini G, Cibelli G, Rougon G, Mattei MG, Goridis C (1989) The mouse
neuronal cell surface protein F3: a phosphatidylinositol-anchored member of the
immunoglobulin superfamily related to chicken contactin. J Cell Biol 109:
775–788.
2. Gennarini G, Durbec P, Boned A, Rougon G, Goridis C (1991) Transfected F3/
F11 neuronal cell surface protein mediates intercellular adhesion and promotes
neurite outgrowth. Neuron 6: 595–606.
3. Durbec P, Gennarini G, Goridis C, Rougon G (1992) A soluble form of the F3
neuronal cell adhesion molecule promotes neurite outgrowth. J Cell Biol 117:
877–887.
4. Pesheva P, Gennarini G, Goridis C, Schachner M (1993) The F3/11 cell
adhesion molecule mediates the repulsion of neurons by the extracellular matrix
glycoprotein J1-160/180. Neuron 10: 69–82.
5. Rathjen FG, Wolff JM, Chang S, Bonhoeffer F, Raper JA (1987) Neurofascin: a
novel chick cell-surface glycoprotein involved in neurite-neurite interactions.
Cell 51: 841–849.
6. Chang S, Rathjen FG, Raper JA (1987) Extension of neurites on axons is
impaired by antibodies against specific neural cell surface glycoproteins. J Cell
Biol 104: 355–362.
7. Buttiglione M, Revest JM, Rougon G, Faivre-Sarrailh C (1996) F3 neuronal
adhesion molecule controls outgrowth and fasciculation of cerebellar granule cell
neurites: a cell-type-specific effect mediated by the Ig-like domains. Mol Cell
Neurosci 8: 53–69.
8. Buttiglione M, Revest JM, Pavlou O, Karagogeos D, Furley A, et al. (1998) A
functional interaction between the neuronal adhesion molecules TAG-1 and F3
modulates neurite outgrowth and fasciculation of cerebellar granule cells.
J Neurosci 18: 6853–6870.
9. Brummendorf T, Hubert M, Treubert U, Leuschner R, Tarnok A, et al. (1993)
The axonal recognition molecule F11 is a multifunctional protein: specific
domains mediate interactions with Ng-CAM and restrictin. Neuron 10:
711–727.
10. Morales G, Hubert M, Brummendorf T, Treubert U, Tarnok A, et al. (1993)
Induction of axonal growth by heterophilic interactions between the cell surface
recognition proteins F11 and Nr-CAM/Bravo. Neuron 11: 1113–1122.
11. Sakurai T, Lustig M, Nativ M, Hemperly JJ, Schlessinger J, et al. (1997)
Induction of neurite outgrowth through contactin and Nr-CAM by extracellular
regions of glial receptor tyrosine phosphatase beta. J Cell Biol 136: 907–918.
12. Volkmer H, Zacharias U, Norenberg U, Rathjen FG (1998) Dissection of
complex molecular interactions of neurofascin with axonin-1, F11, and tenascin-
R, which promote attachment and neurite formation of tectal cells. J Cell Biol
142: 1083–1093.
13. Zisch AH, D’Alessandri L, Ranscht B, Falchetto R, Winterhalter KH, et al.
(1992) Neuronal cell adhesion molecule contactin/F11 binds to tenascin via its
immunoglobulin-like domains. J Cell Biol 119: 203–213.
14. Peles E, Nativ M, Lustig M, Grumet M, Schilling J, et al. (1997) Identification of
a novel contactin-associated transmembrane receptor with multiple domains
implicated in protein-protein interactions. Embo J 16: 978–988.
15. Compton AG, Albrecht DE, Seto JT, Cooper ST, Ilkovski B, et al. (2008)
Mutations in contactin-1, a neural adhesion and neuromuscular junction
protein, cause a familial form of lethal congenital myopathy. Am J Hum Genet
83: 714–724.
16. Jones KJ, Compton AG, Yang N, Mills MA, Peters MF, et al. (2003) Deficiency
of the syntrophins and alpha-dystrobrevin in patients with inherited myopathy.
Neuromuscul Disord 13: 456–467.
17. Berglund EO, Murai KK, Fredette B, Sekerkova G, Marturano B, et al. (1999)
Ataxia and abnormal cerebellar microorganization in mice with ablated
contactin gene expression. Neuron 24: 739–750.
18. Boyle ME, Berglund EO, Murai KK, Weber L, Peles E, et al. (2001) Contactin
orchestrates assembly of the septate-like junctions at the paranode in myelinated
peripheral nerve. Neuron 30: 385–397.
19. Davisson MT (1990) The Jackson Laboratory Mouse Mutant Resource. Lab
Anim 19: 23–29.
20. Green EL (1985) Tables and a computer program for analyzing linkage data.
The Mouse News Letter 73: 20.
21. Burgess RW, Cox GA, Seburn KL (2010) Neuromuscular disease models and
analysis. Methods Mol Biol 602: 347–393.
22. Berglund EO, Ranscht B (1994) Molecular cloning and in situ localization of the
human contactin gene (CNTN1) on chromosome 12q11–q12. Genomics 21:
571–582.
23. Yamagata M, Weiner JA, Sanes JR (2002) Sidekicks: synaptic adhesion
molecules that promote lamina-specific connectivity in the retina. Cell 110:
649–660.
24. Yamagata M, Sanes JR (2008) Dscam and Sidekick proteins direct lamina-
specific synaptic connections in vertebrate retina. Nature 451: 465–469.
25. Fuerst PG, Koizumi A, Masland RH, Burgess RW (2008) Neurite arborization
and mosaic spacing in the mouse retina require DSCAM. Nature 451: 470–474.
26. Fuerst PG, Bruce F, Tian M, Wei W, Elstrott J, et al. (2009) DSCAM and
DSCAML1 function in self-avoidance in multiple cell types in the developing
mouse retina. Neuron 64: 484–497.
27. Gollan L, Sabanay H, Poliak S, Berglund EO, Ranscht B, et al. (2002) Retention
of a cell adhesion complex at the paranodal junction requires the cytoplasmic
region of Caspr. J Cell Biol 157: 1247–1256.
28. Fetissov SO, Bergstrom U, Johansen JE, Hokfelt T, Schalling M, et al. (2005)
Alterations of arcuate nucleus neuropeptidergic development in contactin-
deficient mice:comparison with anorexiaand food-deprivedmice. EurJNeurosci
22: 3217–3228.
A Spontaneous Mutation in Contactin 1 in the Mouse
PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e29538